4.5 Article

Identification of a novel series of potent HCV NS5B Site I inhibitors

Journal

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 24, Issue 8, Pages 1993-1997

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2014.02.047

Keywords

Hepatitis; HCV; Propellane; NS5B; Site I

Ask authors/readers for more resources

investigating spatially comparative alternates of the ethylene-bridged piperazine in BMS-791325 that would offer a maintained or improved virologic and pharmacokinetic profile have been multifaceted. One foray involved the utilization of various octahydropyrrolo[3,4-c] pyrrole propellanes. Many of the propellane analogs described in this work exhibited better than targeted potency ( less than 20 nM). Additionally, improved exposure in rats was achieved through the employment of two newly invented and now readily accessible carbon bridged propellanes as compared to their heteroatom bridged analogs. (C) 2014 Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Medicinal

Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir

Nicholas A. Meanwell, Mark R. Krystal, Beata Nowicka-Sans, David R. Langley, David A. Conlon, Martin D. Eastgate, Dennis M. Grasela, Peter Timmins, Tao Wang, John F. Kadow

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Pharmacology & Pharmacy

Bioactivation of cyclopropyl rings by P450: an observation encountered during the optimisation of a series of hepatitis C virus NS5B inhibitors

Xiaoliang Zhuo, Ying-Zi Wang, Kap-Sun Yeung, Juliang Zhu, Xiaohua Stella Huang, Kyle E. Parcella, Kyle J. Eastman, John F. Kadow, Nicholas A. Meanwell, Yue-Zhong Shu, Benjamin M. Johnson

XENOBIOTICA (2018)

Article Chemistry, Medicinal

The design, synthesis and structure-activity relationships associated with C28 amine-based betulinic acid derivatives as inhibitors of HIV-1 maturation

Yan Chen, Sing-Yuen Sit, Jie Chen, Jacob J. Swidorski, Zheng Liu, Ny Sin, Brian L. Venables, Dawn D. Parker, Beata Nowicka-Sans, Zeyu Lin, Zhufang Li, Brian J. Terry, Tricia Protack, Sandhya Rahematpura, Umesh Hanumegowda, Susan Jenkins, Mark Krystal, Ira D. Dicker, Nicholas A. Meanwell, Alicia Regueiro-Ren

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)

Article Chemistry, Medicinal

P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donor

Brian L. Venables, Ny Sin, Alan Xiangdong Wang, Li-Qiang Sun, Yong Tu, Dennis Hernandez, Amy Sheaffer, Min Lee, Cindy Dunaj, Guangzhi Zhai, Diana Barry, Jacques Friborg, Fei Yu, Jay Knipe, Jason Sandquist, Paul Falk, Dawn Parker, Andrew C. Good, Ramkumar Rajamani, Fiona McPhee, Nicholas A. Meanwell, Paul M. Scola

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)

Article Chemistry, Medicinal

The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease

Michael Bowsher, Sheldon Hiebert, Rongti Li, Alan X. Wang, Jacques Friborg, Fei Yu, Dennis Hernandez, Ying-Kai Wang, Herbert Klei, Ramkumar Rajamani, Kathy Mosure, Jay O. Knipe, Nicholas A. Meanwell, Fiona McPhee, Paul M. Scola

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)

Article Chemistry, Medicinal

Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors

Yong-Jin Wu, Jason Guernon, Andrea McClure, Brian Venables, Ramkumar Rajamani, Kevin J. Robbins, Ronald J. Knox, Michele Matchett, Rick L. Pieschl, James Herrington, Linda J. Bristow, Nicholas A. Meanwell, Richard Olson, Lorin A. Thompson, Carolyn Dzierba

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)

Article Chemistry, Medicinal

The discovery and preclinical evaluation of BMS-707035, a potent HIV-1 integrase strand transfer inhibitor

B. Narasimhulu Naidu, Michael A. Walker, Margaret E. Sorenson, Yasutsugu Ueda, John D. Matiskella, Timothy P. Connolly, Ira B. Dicker, Zeyu Lin, Sagarika Bollini, Brian J. Terry, Helen Higley, Ming Zheng, Dawn D. Parker, Dedong Wu, Stephen Adams, Mark R. Krystal, Nicholas A. Meanwell

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)

Editorial Material Chemistry, Medicinal

Allosteric Modulators of Drug Targets Special Issue

Carrie Haskell-Luevano, Gunda I. Georg, Shaomeng Wang, Nicholas Meanwell

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Coupling of an Acyl Migration Prodrug Strategy with Bio-activation To Improve Oral Delivery of the HIV-1 Protease Inhibitor Atazanavir

Murugaiah A. M. Subbaiah, Nicholas A. Meanwell, John F. Kadow, Lakshumanan Subramani, Mathiazhagan Annadurai, Thangeswaran Ramar, Salil D. Desai, Sarmistha Sinha, Murali Subramanian, Sandhya Mandlekar, Srikanth Sridhar, Shweta Padmanabhan, Priyadeep Bhutani, Rambabu Arla, Susan M. Jenkins, Mark R. Krystal, Chunfu Wang, Ramakanth Sarabu

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Design, Synthesis, and SAR of C-3 Benzoic Acid, C-17 Triterpenoid Derivatives. Identification of the HIV-1 Maturation Inhibitor 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-((2-(1,1-Dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoic Acid (GSK3532795, BMS-955176)

Alicia Regueiro-Ren, Jacob J. Swidorski, Zheng Liu, Yan Chen, Ny Sin, Sing-Yuen Sit, Jie Chen, Brian L. Venables, Juliang Zhu, Beata Nowicka-Sans, Tricia Protack, Zeyu Lin, Brian Terry, Himadri Samanta, Sharon Zhang, Zhufang Li, John Easter, Brett R. Beno, Vinod Arora, Xiaohua S. Huang, Sandhya Rahematpura, Dawn D. Parker, Roy Haskell, Kenneth S. Santone, Mark I. Cocket, Mark Krystal, Nicholas A. Meanwell, Susan Jenkins, Umesh Hanumegowda, Ira B. Dicker

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Discovery of new indole-based acylsulfonamide Nav1.7 inhibitors

Yong-Jin Wu, Brian Venables, Jason Guernon, Jie Chen, Sing-Yuen Sit, Ramkumar Rajamani, Ronald J. Knox, Michele Matchett, Rick L. Pieschl, James Herrington, Linda J. Bristow, Nicholas A. Meanwell, Lorin A. Thompson, Carolyn Dzierba

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)

Article Chemistry, Medicinal

5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors

Kevin M. Peese, Christopher W. Allard, Timothy Connolly, Barry L. Johnson, Chen Li, Manoj Patel, Margaret E. Sorensen, Michael A. Walker, Nicholas A. Meanwell, Brian McAuliffe, Beatrice Minassian, Mark Krystal, Dawn D. Parker, Hal A. Lewis, Kevin Kish, Ping Zhang, Robert T. Nolte, Jean Simmermacher, Susan Jenkins, Christopher Cianci, B. Narasimhulu Naidu

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain

Guanglin Luo, Ling Chen, Amy Easton, Amy Newton, Clotilde Bourin, Eric Shields, Kathy Mosure, Matthew G. Soars, Ronald J. Knox, Michele Matchett, Rick L. Pieschl, Debra J. Post-Munson, Shuya Wang, James Herrington, John Graef, Kimberly Newberry, Digavalli V. Sivarao, Arun Senapati, Linda J. Bristow, Nicholas A. Meanwell, Lorin A. Thompson, Carolyn Dzierba

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Editorial Material Chemistry, Medicinal

Allosteric Modulators of Drug Targets

Carrie Haskell-Luevano, Nicholas A. Meanwell

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

Structure-Property Basis for Solving Transporter-Mediated Efflux and Pan-Genotypic Inhibition in HCV NS5B Inhibitors

Kap-Sun Yeung, Brett R. Beno, Kathy Mosure, Juliang Zhu, Katherine A. Grant-Young, Kyle Parcella, Prakash Anjanappa, Rajesh Onkardas Bora, Kumaravel Selvakumar, Yin-Kai Wang, Hua Fang, Rudolph Krause, Karen Rigat, Mengping Liu, Julie Lemm, Steven Sheriff, Mark Witmer, Jeffrey Tredup, Adam Jardel, Kevin Kish, Dawn Parker, Roy Haskell, Kenneth Santone, Nicholas A. Meanwell, Matthew G. Soars, Susan B. Roberts, John F. Kadow

ACS MEDICINAL CHEMISTRY LETTERS (2018)

Article Chemistry, Medicinal

Design and synthesis of a library of C2-substituted sulfamidoadenosines to probe bacterial permeability

Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan

Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies

Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang

Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake - The importance of chirality and ring size of cyclic amines

Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman

Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2)

Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li

Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: α-Synuclein aggregation inhibition and disaggregation of preformed fibers

Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang

Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel cationic liposomes loaded with melphalan for the treatment of cancer

Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla

Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)